Department of Radiation Oncology, School of Medicine, Winship Cancer Institute of Emory University, Atlanta, Georgia 30322.
Radiat Res. 2014 Oct;182(4):458-61. doi: 10.1667/RR13857.1. Epub 2014 Sep 17.
Ionizing radiation kills cells mainly due to the generation of DNA double-strand breaks (DSBs). High-linear energy transfer (LET) ionizing radiation induces more cell death and generates a higher relative biological effect (RBE) than low-LET ionizing radiation (such as X or γ ray). Although it is known that interference with the Ku-dependent nonhomologous ending-joining (NHEJ) pathway appears to be the major cause of iron-ion- and carbon-ion-induced cell death, it remains unclear whether other ions with a similar or different LET and higher RBE in terms of cell killing are controlled in the same way. In this study, we compared the clonogenic survival frequency of Ku80+/+ (NHEJ-proficient) and Ku80-/- (NHEJ-deficient) cells after exposure to iron (175 keV/μm), silicon (75 keV/μm), oxygen (25 keV/μm) and X ray (low-LET). The results showed that Ku80-/- cells had the same RBE value of 1 for cell killing for all types of ionizing radiation, whereas Ku80+/+ cells had different RBE values for cell killing that depended on the specific type of ionizing radiation. The results indicate that the Ku-dependent NHEJ is the major repair pathway that heavier ions interfere with, resulting in higher RBE for cell killing. These results provide useful information for followup studies that will focus on improving high-LET protection or heavier ion radiotherapy in the near future.
电离辐射主要通过产生 DNA 双链断裂 (DSB) 来杀死细胞。高线性能量转移 (LET) 电离辐射比低 LET 电离辐射(如 X 射线或 γ 射线)诱导更多的细胞死亡并产生更高的相对生物学效应 (RBE)。虽然已知干扰 Ku 依赖性非同源末端连接 (NHEJ) 途径似乎是铁离子和碳离子诱导细胞死亡的主要原因,但尚不清楚其他具有相似或不同 LET 和更高细胞杀伤 RBE 的离子是否以相同的方式受到控制。在这项研究中,我们比较了 Ku80+/+(NHEJ 有效)和 Ku80-/-(NHEJ 缺陷)细胞暴露于铁 (175 keV/μm)、硅 (75 keV/μm)、氧 (25 keV/μm) 和 X 射线(低 LET)后的集落形成存活频率。结果表明,Ku80-/-细胞对所有类型的电离辐射的细胞杀伤 RBE 值均为 1,而 Ku80+/+细胞的细胞杀伤 RBE 值因特定类型的电离辐射而异。结果表明,Ku 依赖性 NHEJ 是重离子干扰的主要修复途径,导致细胞杀伤的 RBE 更高。这些结果为未来的研究提供了有用的信息,这些研究将集中于提高高 LET 保护或重离子放疗。